Fox Run Management L.L.C. raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 264.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 72,189 shares of the company's stock after acquiring an additional 52,372 shares during the quarter. Bath & Body Works accounts for about 0.3% of Fox Run Management L.L.C.'s holdings, making the stock its 25th biggest position. Fox Run Management L.L.C.'s holdings in Bath & Body Works were worth $2,189,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of BBWI. LPL Financial LLC raised its stake in shares of Bath & Body Works by 48.3% during the 4th quarter. LPL Financial LLC now owns 26,117 shares of the company's stock worth $1,013,000 after buying an additional 8,511 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Bath & Body Works by 21.7% during the 4th quarter. Envestnet Asset Management Inc. now owns 168,736 shares of the company's stock worth $6,542,000 after buying an additional 30,042 shares during the last quarter. Cerity Partners LLC raised its stake in shares of Bath & Body Works by 40.1% during the 4th quarter. Cerity Partners LLC now owns 35,145 shares of the company's stock worth $1,288,000 after buying an additional 10,052 shares during the last quarter. Invesco Ltd. raised its stake in shares of Bath & Body Works by 22.6% during the 4th quarter. Invesco Ltd. now owns 711,664 shares of the company's stock worth $27,591,000 after buying an additional 130,972 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Bath & Body Works during the 4th quarter worth $26,491,000. Institutional investors and hedge funds own 95.14% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on BBWI shares. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. UBS Group lifted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Citigroup lifted their price objective on Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. Finally, Barclays dropped their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus target price of $42.19.
Read Our Latest Research Report on Bath & Body Works
Bath & Body Works Trading Up 5.2%
BBWI traded up $1.48 during midday trading on Monday, hitting $30.16. The company's stock had a trading volume of 6,902,169 shares, compared to its average volume of 5,105,490. The firm has a market cap of $6.38 billion, a P/E ratio of 8.04, a PEG ratio of 0.96 and a beta of 1.54. The firm has a 50-day moving average price of $29.92 and a two-hundred day moving average price of $31.21. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the business earned $0.38 EPS. The company's revenue for the quarter was up 2.9% on a year-over-year basis. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. Bath & Body Works's payout ratio is presently 21.33%.
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.